Liposomal encapsulation enhances and prolongs the anti-inflammatory effects of water-soluble dexamethasone phosphate in experimental adjuvant arthritis.
about
Progress in intra-articular therapyImmunosuppressive and anti-inflammatory properties of engineered nanomaterialsNanomedicine delivers promising treatments for rheumatoid arthritisIntravenous delivery of HIV-based lentiviral vectors preferentially transduces F4/80+ and Ly-6C+ cells in spleen, important target cells in autoimmune arthritis.Development of a novel cell-based assay system EPISSAY for screening epigenetic drugs and liposome formulated decitabine.Targeting the hemoglobin scavenger receptor CD163 in macrophages highly increases the anti-inflammatory potency of dexamethasone.Milatuzumab-conjugated liposomes as targeted dexamethasone carriers for therapeutic delivery in CD74+ B-cell malignancies.Benefits and risks of low-dose glucocorticoid treatment in the patient with rheumatoid arthritis.Novel Drug Delivery Systems Tailored for Improved Administration of Glucocorticoids.Liposomal formulation of chondroitin sulfate enhances its antioxidant and anti-inflammatory potential in L929 fibroblast cell line.Limethason reduces airway inflammation in a murine model of ovalbumin-induced chronic asthma without causing side effects.Delivery of anti-inflammatory peptides from hollow PEGylated poly(NIPAM) nanoparticles reduces inflammation in an ex vivo osteoarthritis model.Collagen-binding nanoparticles for extracellular anti-inflammatory peptide delivery decrease platelet activation, promote endothelial migration, and suppress inflammation.Application of liposomes in treatment of rheumatoid arthritis: quo vadis
P2860
Q26851258-1DC9B9D6-CE41-4177-A81D-A294E41A20A0Q27005267-ED13371E-558A-4822-9B96-6024957B75C6Q27021438-DF7D4DF7-C917-4F16-B871-C81452A95B29Q34580053-1129981B-547E-4A84-8CB4-CF8176A20D46Q34622598-9A2F4009-9ACD-4B0A-811F-080B29C14982Q36142511-36F7E26C-60BD-41AE-9E8A-62F5D7D73FAFQ37221480-9CACF73E-18C3-4EE7-882A-93019227AF77Q38204350-08A42EE2-AFC4-411C-A841-D8D2B7512D23Q38637805-3EDCCAA2-A930-4CC0-AA36-629F2A8ADDF0Q39165523-93E1E7B6-DC79-446A-97F6-27577CEB0E96Q49884482-F83FE31A-D1F7-4289-88BC-46B675A894D6Q50879036-CB9BE1A7-CE49-4560-8578-A8436079593BQ51101323-02E2D5C2-6B2B-4E3C-8205-0EC40190B69CQ59101195-25E3528F-BA20-4F17-878B-53ADD9779577
P2860
Liposomal encapsulation enhances and prolongs the anti-inflammatory effects of water-soluble dexamethasone phosphate in experimental adjuvant arthritis.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Liposomal encapsulation enhanc ...... perimental adjuvant arthritis.
@ast
Liposomal encapsulation enhanc ...... perimental adjuvant arthritis.
@en
Liposomal encapsulation enhanc ...... perimental adjuvant arthritis.
@nl
type
label
Liposomal encapsulation enhanc ...... perimental adjuvant arthritis.
@ast
Liposomal encapsulation enhanc ...... perimental adjuvant arthritis.
@en
Liposomal encapsulation enhanc ...... perimental adjuvant arthritis.
@nl
prefLabel
Liposomal encapsulation enhanc ...... perimental adjuvant arthritis.
@ast
Liposomal encapsulation enhanc ...... perimental adjuvant arthritis.
@en
Liposomal encapsulation enhanc ...... perimental adjuvant arthritis.
@nl
P2093
P2860
P356
P1476
Liposomal encapsulation enhanc ...... perimental adjuvant arthritis.
@en
P2093
Alexandros P Siskos
Angels Franch
Constantin Tamvakopoulos
Dirk Pohlers
Francisco J Perez-Cano
Margarida Castell
Mieczyslaw Gajda
Raimund W Kinne
Rebecca Anderson
Rolf Bräuer
P2860
P2888
P356
10.1186/AR3089
P577
2010-07-19T00:00:00Z
P5875
P6179
1017683769